Boston Scientific Hit by Cyberattack, Operations Disrupted and Shares Slide

Boston Scientific, the $72 billion medical-device maker headquartered in Natick, Massachusetts, disclosed that a cyberattack this week has compromised its internal information systems and applications. The breach is affecting functions that support shipment services and other operational processes.

CNBC

Following the disclosure, Boston Scientific’s shares fell about 5 % in pre-market trading on Wednesday. The decline adds to a broader downward trend; the company’s stock has been nearly halved this year after a weak first-quarter profit forecast pressured investors. The market reaction reflects concerns that the cyber incident could further impair revenue generation and delay product deliveries.

CNBC

Boston Scientific’s public statement emphasized ongoing remediation efforts and coordination with cybersecurity experts, though specific details of the attack—such as the vector or responsible party—were not disclosed. The filing noted that the company continues to monitor the situation and will update stakeholders as restoration progresses. No estimate for when all systems will be fully operational was given.

CNBC

The incident underscores the vulnerability of health-technology firms to cyber threats that can interrupt critical supply chains and patient-care services. Analysts have highlighted that prolonged system outages could affect the timely delivery of devices such as pacemakers and stents, potentially prompting heightened regulatory scrutiny and prompting other manufacturers to reassess their cybersecurity defenses. The episode adds to a growing pattern of cyber incidents targeting high-value, data-intensive industries.

CNBC